Why Indian pharma isn’t panicking on Trump’s threat of 200% tariff on generics – Moneycontrol.com(Soban News)

1. Why Indian pharma isn’t panicking on Trump’s threat of 200% tariff on generics  Moneycontrol.com
2. Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines  The Times of India
3. Trump rolls out new tariff policy for generic medicines, 200% levy to kick in after August 2028 transition  Deccan Herald
4. Indias Generic Drug Exports Now Face New US Tariff Threat  TheWire.in
5. Trump’s tariff threat on generic drugs: Why this matters for Indian pharma companies  The Indian Express

​Why Indian pharma isn’t panicking on Trump’s threat of 200% tariff on generics  Moneycontrol.comTrump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines  The Times of IndiaTrump rolls out new tariff policy for generic medicines, 200% levy to kick in after August 2028 transition  Deccan HeraldIndias Generic Drug Exports Now Face New US Tariff Threat  TheWire.inTrump’s tariff threat on generic drugs: Why this matters for Indian pharma companies  The Indian Express by Soban News (international And National News)